SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-022046
Filing Date
2024-02-28
Accepted
2024-02-28 16:02:29
Documents
16
Period of Report
2024-02-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aclx-20240228.htm   iXBRL 8-K 41593
2 EX-99.1 aclx-ex99_1.htm EX-99.1 33264
3 GRAPHIC img167846775_0.jpg GRAPHIC 4721
4 GRAPHIC img167846775_1.jpg GRAPHIC 18064
5 GRAPHIC img167846775_2.jpg GRAPHIC 50669
  Complete submission text file 0000950170-24-022046.txt   295965

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT aclx-20240228.xsd EX-101.SCH 25007
17 EXTRACTED XBRL INSTANCE DOCUMENT aclx-20240228_htm.xml XML 4744
Mailing Address 800 BRIDGE PARKWAY REDWOOD CITY CA 94065
Business Address 800 BRIDGE PARKWAY REDWOOD CITY CA 94065 240-327-0603
Arcellx, Inc. (Filer) CIK: 0001786205 (see all company filings)

IRS No.: 472855917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41259 | Film No.: 24695070
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)